Haemophilia trials in Denmark

5 of 11 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  Where

  Copenhagen Oe

  Age

  12 years and over

  People

  360 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07416604 · EU 2025-522435-33-00
• Phase 3Taking people
  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  Where

  Aarhus N

  Age

  18 years and over

  People

  84 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07830732 · EU 2026-525529-19-00
• Phase 3Taking people
  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Where

  Aarhus N, Copenhagen Oe

  Age

  1 year to 74 years

  People

  245 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05145127 · EU 2022-500470-33-00
• Phase 3Taking people
  A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

  Where

  Copenhagen Oe

  Age

  12 years and over

  People

  138 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07416526 · EU 2025-522434-32-00
• Phase 3Taking people
  A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

  Where

  Aarhus N, Copenhagen Oe

  Age

  1 year to 17 years

  People

  100 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05611801 · EU 2022-500495-65-00